Therapeutic drug monitoring of long-acting injectable antipsychotics and psychopathological assessment in schizophrenia spectrum disorders: a longitudinal characterisation of relapse risk

Schizophrenia Spectrum Antipsychotic drug
DOI: 10.1016/j.nsa.2024.104616 Publication Date: 2024-12-20T16:56:49Z